Package 66658-501-01

Brand: gamifant

Generic: emapalumab-lzsg
NDC Package

Package Facts

Identity

Package NDC 66658-501-01
Digits Only 6665850101
Product NDC 66658-501
Description

1 VIAL, SINGLE-USE in 1 CARTON (66658-501-01) / 2 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2019-05-17
Brand gamifant
Generic emapalumab-lzsg
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8ad514da-e74a-48bb-bcd1-6c8b39cb89f9", "openfda": {"nui": ["N0000193856", "N0000193855"], "unii": ["3S252O2Z4X"], "rxcui": ["2104611", "2104616", "2104621", "2104622", "2380771", "2380772", "2665325", "2665328", "2665330", "2665331", "2665332", "2665333", "2665334", "2665335"], "spl_set_id": ["a865e0ef-8685-4f69-8838-648c4f3bab47"], "pharm_class_epc": ["Interferon gamma Blocker [EPC]"], "pharm_class_moa": ["Interferon gamma Antagonists [MoA]"], "manufacturer_name": ["Swedish Orphan Biovitrum AB (publ)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (66658-501-01)  / 2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "66658-501-01", "marketing_start_date": "20190517"}], "brand_name": "GAMIFANT", "product_id": "66658-501_8ad514da-e74a-48bb-bcd1-6c8b39cb89f9", "dosage_form": "INJECTION", "pharm_class": ["Interferon gamma Antagonists [MoA]", "Interferon gamma Blocker [EPC]"], "product_ndc": "66658-501", "generic_name": "emapalumab-lzsg", "labeler_name": "Swedish Orphan Biovitrum AB (publ)", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GAMIFANT", "active_ingredients": [{"name": "EMAPALUMAB", "strength": "10 mg/2mL"}], "application_number": "BLA761107", "marketing_category": "BLA", "marketing_start_date": "20190517", "listing_expiration_date": "20261231"}